purine has been researched along with mpi-0479605 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bradford, C; Bursavich, M; Carlson, RO; Chan, A; Cimbora, DM; Gerrish, D; Hoarau, C; McKinnon, R; Papac, DI; Patton, S; Reeves, L; Roth, BL; Saunders, M; Shenderovich, M; Slattum, P; Vijay Kumar, D; Williams, BL; Yager, K | 1 |
1 other study(ies) available for purine and mpi-0479605
Article | Year |
---|---|
Lead optimization of purine based orally bioavailable Mps1 (TTK) inhibitors.
Topics: Adenine; Administration, Oral; Animals; Apoptosis; Binding Sites; Crystallography, X-Ray; G2 Phase Cell Cycle Checkpoints; HCT116 Cells; Humans; M Phase Cell Cycle Checkpoints; Mice; Molecular Conformation; Morpholines; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Purines; Structure-Activity Relationship | 2012 |